Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic analysis of intrahospital transmission of carbapenem-resistant Gram-negative bacteria: a multicentre study in Japan.

Microbial genomics·2026
Same author

Therapeutic drug monitoring-guided linezolid salvage therapy for Lacticaseibacillus paracasei infective endocarditis: A case report.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same author

Malignant Mesothelioma Diagnosed From a Spermatic Cord Lesion After Inconclusive Thoracoscopy: A Case With Concomitant Pleural and Peritoneal Involvement.

Cureus·2026
Same author

Native Wrist Septic Arthritis due to Corynebacterium striatum after Short-Term Systemic Glucocorticoids.

Internal medicine (Tokyo, Japan)·2026
Same author

[Hepatosplenic T-cell lymphoma with pancytopenia and massive splenomegaly].

[Rinsho ketsueki] The Japanese journal of clinical hematology·2026
Same author

Addition of High-Dose Cytarabine to Fludarabine, Busulfan, and Melphalan Conditioning for Cord Blood Transplantation in Adult Acute Myeloid Leukemia.

Transplantation and cellular therapy·2026

Related Experiment Video

Updated: May 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Necrotizing pneumonia in the community.

Hiroshi Otera1, Go Yamamoto, Kiyofumi Ohkusu

  • 1Department of Respiratory Medicine, Nishi-Kobe Medical Center, Japan. h.otera@onh.go.jp

Internal Medicine (Tokyo, Japan)
|September 15, 2012
PubMed
Summary

A fatal case of necrotizing pneumonia caused by both methicillin-sensitive and methicillin-resistant Staphylococcus aureus (MSSA and MRSA) strains is presented. The patient

More Related Videos

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Experiment Videos

Last Updated: May 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Necrotizing pneumonia is a severe lung infection.
  • Staphylococcus aureus, including MRSA, can cause severe pneumonia.
  • Distinguishing between MSSA and MRSA infections is crucial for treatment.

Observation:

  • A 62-year-old male presented with fatigue, diagnosed with septic shock and severe pneumonia.
  • Initial sputum cultures identified both methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA).
  • Chest CT revealed multilobar cavitary lesions, and subsequent cultures confirmed only MRSA.

Findings:

  • The patient's condition did not improve with initial antibiotic treatment.
  • Despite vancomycin therapy for MRSA, the patient developed necrotizing pneumonia and ultimately died.
  • Autopsy revealed extensive gram-positive cocci in the lungs.
  • The clinical presentation differed from typical community-acquired MRSA (CA-MRSA) necrotizing pneumonia.

Implications:

  • This case highlights the challenges in treating severe MRSA pneumonia, especially when presenting atypically.
  • Necrotizing pneumonia due to MRSA can have a fulminant course and high mortality.
  • Further research into the specific virulence factors and treatment strategies for atypical MRSA pneumonia is warranted.